Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

AIMS: The aim of this study was to compare long-term safety and efficacy of the basal insulin analogue degludec with glargine in insulin-naive subjects with Type 2 diabetes. METHODS: This open-label trial included a 52-week core period followed by a 52-week extension. Participants were randomized 3:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Philis-Tsimikas, A, Skjøth, T V, Rana, A, Mathieu, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208679/
https://www.ncbi.nlm.nih.gov/pubmed/23952326
http://dx.doi.org/10.1111/dme.12303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208679/
https://www.ncbi.nlm.nih.gov/pubmed/23952326
http://dx.doi.org/10.1111/dme.12303

Ejemplares similares